In Vivo Imaging of the Tumor-Associated Enzyme NCEH1 with a Covalent PET Probe

Angew Chem Int Ed Engl. 2020 Aug 24;59(35):15161-15165. doi: 10.1002/anie.202004762. Epub 2020 Jun 15.

Abstract

Herein, we report the development of an 18 F-labeled, activity-based small-molecule probe targeting the cancer-associated serine hydrolase NCEH1. We undertook a focused medicinal chemistry campaign to simultaneously preserve potent and specific NCEH1 labeling in live cells and animals, while permitting facile 18 F radionuclide incorporation required for PET imaging. The resulting molecule, [18 F]JW199, labels active NCEH1 in live cells at nanomolar concentrations and greater than 1000-fold selectivity relative to other serine hydrolases. [18 F]JW199 displays rapid, NCEH1-dependent accumulation in mouse tissues. Finally, we demonstrate that [18 F]JW199 labels aggressive cancer tumor cells in vivo, which uncovered localized NCEH1 activity at the leading edge of triple-negative breast cancer tumors, suggesting roles for NCEH1 in tumor aggressiveness and metastasis.

Keywords: NCEH1; activity-based probes; imaging; positron emission tomography; radiotracers.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Female
  • Fluorine Radioisotopes / therapeutic use*
  • Humans
  • Mice
  • Positron-Emission Tomography / methods*
  • Sterol Esterase / metabolism*

Substances

  • Fluorine Radioisotopes
  • Nceh1 protein, mouse
  • Sterol Esterase